Exercise and Diet Program for Schizophrenia Patients Who Are Taking Atypical Antipsychotic Medications

Sheba Medical Center100 enrolled

Overview

In this study the investigators will recruit patients with the diagnosis of schizophrenia that are taking atypical neuroleptics and that are willing to participate in an exercise and diet program. The investigators will measure weight and abdomen circumference.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

NONE

Enrollment

100

Conditions

Schizophrenia

Interventions

Exercise programBEHAVIORAL

Homogenous exercise program in local fitness centers

DietBEHAVIORAL

Weigh loss diet program prescribed by a professional nutritionist

Eligibility

Sex: ALLMin age: 18 YearsMax age: 35 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Schizophrenia * Atypical neuroleptics Exclusion Criteria: * Medical illness preventing exercise

Locations (1)

Sheba Medical Center

Tel Litwinsky, Ramat Gan, Israel

Outcomes

Primary Outcomes

Weight loss

The weight of the participants of the trial was monitored during the trial, while they were following the exercise program and the diet, starting from the baseline until end of study/early withdrawal.

Time frame: One year

Secondary Outcomes

Abdomen circumference

The circumference of the abdomen of the participants of the trial was monitored during the trial, while they were following the exercise program and the diet, starting from the baseline until end of study/early withdrawal.

Time frame: One year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.